Glucose infusion does not suppress increased lipolysis after abdominal surgery

Citation
T. Schricker et al., Glucose infusion does not suppress increased lipolysis after abdominal surgery, NUTRITION, 17(2), 2001, pp. 85-90
Citations number
23
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
NUTRITION
ISSN journal
08999007 → ACNP
Volume
17
Issue
2
Year of publication
2001
Pages
85 - 90
Database
ISI
SICI code
0899-9007(200102)17:2<85:GIDNSI>2.0.ZU;2-M
Abstract
The purpose of this study was to investigate the effect of glucose infusion on lipid metabolism after abdominal surgery. Patients (n = 6) with non-met astasized colorectal carcinoma were investigated on the second day after su rgery and healthy volunteers were studied after an overnight fast. The rate s of glycerol appearance (R-a glycerol), i.e., lipolysis rates, were assess ed by primed continuous infusion of [1,1,2,3,3, H-5(2)] glycerol before and after 3 h of glucose infusion (4 mg(.)kg(-1.)min(-1)). Plasma concentratio ns of glycerol, free fatty acids, glucose, lactate, insulin, and glucagon w ere determined. Fasting R-a glycerol was higher in patients than in volunte ers (7.7 +/- 1.8 versus 1.9 +/- 0.3 mu mol(.)kg(-1.)min(-1), P < 0.05). Glu cose infusion suppressed the R-a glycerol in volunteers to 1.0 +/- 0.2 <mu> mol(.)kg(-1.)min(-1) (P < 0.05), whereas lipolysis was not affected in-pati ents. Plasma concentrations of glycerol and free fatty acids similarly decr eased during glucose administration by 50% in both groups (P < 0.05). In co ntrast to the patients, a significant correlation (r = 0.78, P < 0.05) betw een the R-a glycerol and plasma glycerol concentration was observed in norm al subjects. The hyperglycemic response to glucose infusion was significant ly more pronounced (P < 0.05) In patients (10.7 +/- 0.7 mmol/L); than in vo lunteers (7.1 +/- 014 mmol/L, whereas the plasma insulin increased to the s ame extent in the two groups (P < 0.001). In conclusion, lipolysis rates ar e increased after abdominal surgery and glucose administration, most likely due to insulin resistance, and fail to inhibit stimulated whole-body lipol ysis. (C) Elsevier Science Inc. 2001.